甲状腺微小乳头状癌的治疗进展

邓婕; 段东; 邓婕; 段东

doi:10.3760/cma.j.issn.1673-4114.2018.05.014

[1]

Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors:a commentary on the second edition[J]. Cancer, 1989, 63 (5):908-911. doi: 10.1002/(ISSN)1097-0142

[2]

林岩松, 杨雪.甲状腺微小癌-¹³¹I治疗[J].中国实用外科杂志, 2016, 36 (5):527-530. DOI:10.7504/CJPS.ISSN 1005-2208. 2016.05.16.
Lin YS, Yang X. Radioactive iodine-131 therapy of papillary thyroid microcarcinoma[J]. Chin J Pract Surg, 2016, 36 (5):527-530. doi: 10.7504/CJPS.ISSN1005-2208.2016.05.16

[3]

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26 (1):1-133. DOI:10.1089/thy.2015.0020.

[4]

Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34 (1):28-35. DOI:10.1007/s00268-009-0303-0.

[5]

Haser GC, Tuttle RM, Su HK, et al. Active surveillance for papillary thyroid microcarcinoma:new challenges and opportunities for the health care system[J]. Endocr Pract, 2016, 22 (5):602-611. DOI:10.4158/EP151065.RA.

[6]

张浩.甲状腺微小乳头状癌外科治疗争议与共识[J].中国实用外科杂志, 2016, 36 (5):504-508. DOI:10.7504/CJPS.ISSN1005-2208.2016.05.09.
Zhang H. Consensus and controversy on surgical treatment of papillary thyroid microcarcinoma[J]. Chin J Pract Surg, 2016, 36 (5):504-508. doi: 10.7504/CJPS.ISSN1005-2208.2016.05.09

[7]

中国抗癌协会甲状腺癌专业委员会.甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J].中国肿瘤临床, 2016, 43 (10):405-411. DOI:10.3969/j.issn.1000-8179.2016.10.001.
China anti-cancer association's specialist committee on thyroid carcinoma. Diagnosis and treatment of papillary thyroid microcarcinoma in China (2016 edition)[J]. Chin J Clin Oncol, 2016, 43 (10):405-411. doi: 10.3969/j.issn.1000-8179.2016.10.001

[8]

Wang TS, Goffredo P, Sosa JA, et al. Papillary thyroid microcarcinoma:an over-treated malignancy?[J]. World J Surg, 2014, 38 (9):2297-2303. DOI:10.1007/s00268-014-2602-3.

[9]

张伟伟, 李向农.三种术式在甲状腺微小乳头状癌外科治疗中的应用效果比较[J].中华普外科手术学杂志(电子版), 2017, 11 (5):397-399. DOI:10.3877/cma.j.issn.1674-3946.2017.05.014.
Zhang WW, Li XN. Three operative procedures in the surgical treatment of papillary thyroid microcarcinoma[J]. Chin J Oper Proc Gen Surg (Electronic Edition), 2017, 11 (5):397-399. doi: 10.3877/cma.j.issn.1674-3946.2017.05.014

[10]

Donatini G, Castagnet M, Desurmont T, et al. Partial Thyroidectomy for Papillary Thyroid Microcarcinoma:Is Completion Total Thyroidectomy Indicated?[J]. World J Surg, 2016, 40 (3):510-515. DOI:10.1007/s00268-015-3327-7.

[11]

朱精强, 雷建勇.甲状腺微小乳头状癌过度治疗与不足[J].中国实用外科杂志, 2016, 36 (5):520-523. DOI:10.7504/CJPS.ISSN 1005-2208.2016.05.14.
Zhu JQ, Lei JY. Over-treatment and under-treatment of papillary thyroid microcarcinoma[J]. Chin J Pract Surg, 2016, 36 (5):520-523. doi: 10.7504/CJPS.ISSN1005-2208.2016.05.14

[12]

Kuo EJ, Goffredo P, Sosa JA, et al. Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases:a population-level analysis[J]. Thyroid, 2013, 23 (10):1305-1311. DOI:10.1089/thy.2012.0563.

[13]

Li F, Chen G, Sheng C, et al. BRAF^V600E mutation in papillary thyroid microcarcinoma:a meta-analysis[J]. Endocr Relat Cancer, 2015, 22 (2):159-168. DOI:10.1530/ERC-14-0531.

[14]

Caliskan M, Park JH, Jeong JS, et al. Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma[J]. Endocr J, 2012, 59 (4):305-311. DOI:10.1507/endocrj.EJ11-0366.

[15]

So YK, Son YI, Hong SD, et al. Subclinical lymph node metastasis in papillary thyroid microcarcinoma:a study of 551 resections[J]. Surgery, 2010, 148 (3):526-531. DOI:10.1016/j.surg.2010.01.003.

[16]

卞雪艳, 孙姗姗, 郭文宇, 等.甲状腺微小乳头状癌颈淋巴结转移的危险因素分析[J].中国肿瘤临床, 2015, 42 (13):658-662. DOI:10.3969/j.issn.1000-8179.20150156.
Bian XY, Sun SS, Guo WY, et al. Risk factor analysis for cervical nodal metastasis in papillary microcarcinoma[J]. Chin J Clin Oncol, 2015, 42 (13):658-662. doi: 10.3969/j.issn.1000-8179.20150156

[17]

边学海, 李世杰, 张广, 等.甲状腺微小乳头状癌颈淋巴结转移影响因素的初步研究(附1180例报道)[J].国际外科学杂志, 2013, 40 (2):105-108. DOI:10.3760/cma.j.issn.1673-4203. 2013. 02.010.
Bian XH, Li SJ, Zhang G, et al. Effective factors of cervical lymph node metastasis of papillary thyroid microcarcinoma (1180 cases)[J].Inter J Surg, 2013, 40 (2):105-108. doi: 10.3760/cma.j.issn.1673-4203.2013.02.010

[18]

刘晓岭, 黄靖, 孙德胜, 等.超声引导下射频消融治疗甲状腺微小乳头状癌的临床体会[J].黑龙江医学, 2015, 39 (1):69-70. DOI:10.3969/j.issn.1004-5775.2015.01.035.
Liu XL, Huang J, Sun DS, et al. Experience of Radiofrequency Ablation Treatment of Thyroid Papillary Microcarcinoma Under Ultrasound Guidance[J]. Heilongjiang Med J, 2015, 39 (1):69-70. doi: 10.3969/j.issn.1004-5775.2015.01.035

[19]

Zhang M, Luo Y, Zhang Y, et al. Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Treating Low-Risk Papillary Thyroid Microcarcinoma:A Prospective Study[J]. Thyroid, 2016, 26 (11):1581-1587. DOI:10.1089/thy.2015.0471.

[20]

李建如, 罗渝昆, 李岩密, 等.超声引导下射频消融治疗甲状腺微小乳头状癌的疗效分析[J].解放军医学院学报, 2016, 37 (8):823-826. DOI:10.3969/j.issn.2095-5227.2016.08.002.
Li JR, Luo YK, Li YM, et al. Effects of radiofrequency ablation guided by ultrasound in treatment of thyroid papillary tiny carcinoma[J]. Acad J Chin PLA Med Sch, 2016, 37 (8):823-826. doi: 10.3969/j.issn.2095-5227.2016.08.002

[21]

张浩, 孙威.射频消融治疗甲状腺微小乳头状癌之我见[J].医学与哲学, 2017, 38 (7B):19-21, 51. DOI:10.12014/j.issn.1002-0772. 2017.07b.05.
Zhang H, Sun W. Personal Insight into Radiofrequency Ablation for the Treatment of papillary Thyroid Microcarcinoma[J]. Med Philos, 2017, 38 (7B):19-21, 51. doi: 10.12014/j.issn.1002-0772.2017.07b.05

[22]

王平, 燕海潮.完全腔镜甲状腺癌手术并发症的防治[J].腹腔镜外科杂志, 2012, 17 (11):806-809. DOI:10.3969/j.issn.1009-6612. 2012.11.003.
Wang P, Yan HC. Prevention and treatment of complications of complete endoscopic thyroid carcinoma[J]. J Laparoscopic Surg, 2012, 17 (11):806-809. doi: 10.3969/j.issn.1009-6612.2012.11.003

[23]

陈峰, 张保根. 90例经胸乳入路腔镜下甲状腺手术[J].中华内分泌外科杂志, 2013, 7 (1):16-18. DOI:10.3760/cma.j.issn.1674-6090.2013.01.006.
Chen F, Zhang BG. Endoscopic thyroidectomy via the breast areolae:90 cases[J]. Chin J Endocr Surg, 2013, 7 (1):16-18. doi: 10.3760/cma.j.issn.1674-6090.2013.01.006

[24]

Mihailovic J, Stefanovic L, Stankovic R. Influence of initial treatment on the survival and recurrence in patients with differentiated thyroid microcarcinoma[J]. Clin Nucl Med, 2013, 38 (5):332-338. DOI:10.1097/RLU.0b013e3182872ed2.

[25]

李志红.促甲状腺激素抑制疗法在分化型甲状腺癌治疗中的作用[J].实用临床医药杂志, 2013, 17 (9):107-108. DOI:10.7619/jcmp.201309039.
Li ZH. Value of thyroid stimulating hormone inhibition therapy in differentiated thyroid carcinoma[J]. J Clin Med Pract, 2013, 17 (9):107-108. doi: 10.7619/jcmp.201309039

[26]

关海霞.甲状腺微小癌术后促甲状腺激素抑制治疗认识和挑战[J].中国实用外科杂志, 2016, 36 (5): 524-527. DOI: 10.7504/CJPS.ISSN1005-2208.2016.05.15.

Guan HX. Thyrotropin suppression therapy in thyroid microcarcinoma: Current understanding and challenges[J]. Chin J Prat Surg, 2016, 36 (5): 524-527.